EE14 Cost of Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.315
https://www.valueinhealthjournal.com/article/S1098-3015(24)00430-3/fulltext
Section Title :
Section Order :
11657
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00430-3&doi=10.1016/j.jval.2024.03.315